- Home
- ALRN vs CLPR Comparison
ALRN vs CLPR Comparison
Compare ALRN & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- CLPR
- Stock Information
- Founded
- ALRN 2001
- CLPR 2015
- Country
- ALRN United States
- CLPR United States
- Employees
- ALRN N/A
- CLPR N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- ALRN Health Care
- CLPR Real Estate
- Exchange
- ALRN Nasdaq
- CLPR Nasdaq
- Market Cap
- ALRN 76.9M
- CLPR 63.5M
- IPO Year
- ALRN 2017
- CLPR 2017
- Fundamental
- Price
- ALRN $3.42
- CLPR $5.41
- Analyst Decision
- ALRN Strong Buy
- CLPR Sell
- Analyst Count
- ALRN 1
- CLPR 2
- Target Price
- ALRN $19.00
- CLPR N/A
- AVG Volume (30 Days)
- ALRN 93.8K
- CLPR 118.4K
- Earning Date
- ALRN 11-26-2024
- CLPR 10-31-2024
- Dividend Yield
- ALRN N/A
- CLPR 7.02%
- EPS Growth
- ALRN N/A
- CLPR N/A
- EPS
- ALRN N/A
- CLPR N/A
- Revenue
- ALRN N/A
- CLPR $145,595,000.00
- Revenue This Year
- ALRN N/A
- CLPR N/A
- Revenue Next Year
- ALRN N/A
- CLPR N/A
- P/E Ratio
- ALRN N/A
- CLPR N/A
- Revenue Growth
- ALRN N/A
- CLPR 6.78
- 52 Week Low
- ALRN $1.57
- CLPR $3.38
- 52 Week High
- ALRN $7.42
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- ALRN 47.41
- CLPR 41.77
- Support Level
- ALRN $3.37
- CLPR $5.42
- Resistance Level
- ALRN $3.92
- CLPR $6.40
- Average True Range (ATR)
- ALRN 0.35
- CLPR 0.35
- MACD
- ALRN -0.06
- CLPR -0.10
- Stochastic Oscillator
- ALRN 21.36
- CLPR 13.48
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.